(2014). Risk of vascular events in patients with polymyalgia rheumatica. Cmaj. http://doi.org/10.1503/cmaj.140266.
(2015). Increased risk of vascular disease associated with gout: a retrospective, matched cohort study in the UK clinical practice research datalink. Ann Rheum Dis. http://doi.org/10.1136/annrheumdis-2014-205252.
(2017). Gout and subsequent erectile dysfunction: a population-based cohort study from England. Arthritis Res Ther. http://doi.org/10.1186/s13075-017-1322-0.
(2017). Incident acute pseudogout and prior bisphosphonate use: Matched case-control study in the UK-Clinical Practice Research Datalink. Medicine (Baltimore). http://doi.org/10.1097/md.0000000000006177.
(2017). Factors Influencing Allopurinol Initiation in Primary Care. Ann Fam Med. http://doi.org/10.1370/afm.2137.
(2018). Risk of chronic kidney disease in patients with gout and the impact of urate lowering therapy: a population-based cohort study. Arthritis Res Ther. http://doi.org/10.1186/s13075-018-1746-1.
(2018). Risk of fracture among patients with polymyalgia rheumatica and giant cell arteritis: a population-based study. BMC Med. http://doi.org/10.1186/s12916-017-0987-1.
(2018). Risk of fragility fracture among patients with gout and the effect of urate-lowering therapy. Cmaj. http://doi.org/10.1503/cmaj.170806.
(2018). Risk of fragility fracture among patients with late-onset psoriasis: a UK population-based study. Osteoporos Int. http://doi.org/10.1007/s00198-018-4491-z.
(2018). The risk of gout among patients with sleep apnea: a matched cohort study. Arthritis Rheumatol. http://doi.org/10.1002/art.40662.